Bristol Myers' Sotyktu, a TYK2 inhibitor already approved for psoriasis, scored a win in a Phase III trial for psoriatic ...

Apple plans to roll out an upgraded Siri by spring 2026 as part of iOS 26.4, turning its assistant into something more ...

Sagace Wealth Management LLC more than doubled its holdings in Meta Platforms during Q1, snapping up 816 shares valued at ...

Berkshire Hathaway, led by investing legend Warren Buffett, holds two dramatically different energy stocks: Occidental ...

Netflix stock dipped 2.7% after two board members sold a sizable chunk of shares, shaking investor confidence. Director Jay ...

Milestone Asset Management slashed its NVIDIA holdings by 21.4% in Q1, reducing its stake to 54,236 shares worth $5.88 ...

AMD unveiled its latest AI arsenal, the Instinct MI350 series, touting 4x more compute and a 35x boost in inference. Despite ...

Merck’s Animal Health division just fetched a major win as the EU's veterinary committee gave a tail-wagging thumbs-up to ...

Wells Fargo has bumped Microsoft’s price target from $515 to $565, signaling confidence in a software rebound post-summer ...

Farther Finance Advisors LLC reduced its RTX holdings by 16.1% in Q1, trimming 8,457 shares but still clinging to 44,067 ...

Zhang Financial LLC ramped up its investment in JPMorgan Chase & Co. by a hefty 57.1% in Q1, adding over 7,000 shares to ...

Tesla shares dipped after renewed political friction threatened a key income stream: zero-emission vehicle credits from ...